Health, C., 2023. CADTH Reimbursement Recommendation - Nelarabine (Atriance) - Indication: Nelarabine (Atriance) for addition to front-line multiagent therapy, Canadian Agency for Drugs and Technologies in Health.
Canada
Retrieved from https://policycommons.net/artifacts/8189956/cadth-reimbursement-recommendation-nelarabine-atriance-indication/9100365/fragments/4338007/ on 27 Jul 2024. CID: 20.500.12592/7kvdbc.
Download citation (RIS)